Crossmark

Use of Patient-Reported Outcome Measures in Clinical Studies of Chronic Myeloid Leukemia: A Scoping Literature Review

Published Online: 2025-10-15

Published Print: 2025-12

Authors

Flynn, Kathryn E.

Saini, Lovneet

Kataria, Aditi

Jadhav, Kejal

Yang, Daisy

Wei, David
License Information

Text and Data Mining valid from 2025-10-15

Version of Record valid from 2025-10-15
More Information

Article History

Received: 25 June 2025

Accepted: 21 August 2025

First Online: 15 October 2025

Declarations

:

: KEF received honoraria from Novartis Pharmaceuticals Corporation. LS, AK, KJ, DY, and DW are Novartis employees.

Document is current